investigator_user investigator user funding collaborators pending menu bell message arrow_up arrow_down filter layers globe marker add arrow close download edit facebook info linkedin minus plus save share search sort twitter remove user-plus user-minus
  • Project leads
  • Collaborators

Identification and validation of synthetic lethality in KRAS mutant lung adenocarcinoma patient derived xenografts

Charles M. Rudin

0 Collaborator(s)

Funding source

National Institutes of Health (NIH)

Related projects

Kelley Lee

Tobacco Companies, Public Policy and Global Health

Trachea, bronchus and lung

Ji Ming Wang

Role of Formylpeptide Receptors in Host Defense

Trachea, bronchus and lung

Joseph R Testa

RIP1/3 Kinases as New Targets in Malignant Mesothelioma

Trachea, bronchus and lung

Pathology

Jeffrey Schlom

Strategies for Cancer Vaccine Development: Preclinical Studies

Trachea, bronchus and lung

Pathology

Roman Perez-Soler

Inhaled DNA demethylating therapy for lung cancer and bronchial premalignancy

Trachea, bronchus and lung

Susan Bates

Investigation of the ABC Half-Transporter ABCG2

Trachea, bronchus and lung

Tyshia Kyree Gwin

Induction of tumor suppressor p16INK4A by human papillomavirus 16 E7 oncoprotein

Trachea, bronchus and lung

Douglas R Green

RIPK-Dependent Necrosis in Development and Cancer

Trachea, bronchus and lung

Douglas Lowy

Tumor gene expression in vitro and in vivo

Trachea, bronchus and lung